title: Comment on Wu and Spiegelman. Irisin ERKs the fat. Diabetes 2014;63:381-383.
authors.affiliation: German Diabetes Center, Paul-Langerhans-Group for Integrative Physiology, Düsseldorf, Germany.
authors.forename: Manuela
authors.initials: M
authors.lastname: Elsen
authors.affiliation: German Diabetes Center, Paul-Langerhans-Group for Integrative Physiology, Düsseldorf, Germany.
authors.forename: Silja
authors.initials: S
authors.lastname: Raschke
authors.affiliation: R&D Diabetes Division, Sanofi, Frankfurt, Germany.
authors.forename: Mark
authors.initials: M
authors.lastname: Sommerfeld
authors.affiliation: R&D Diabetes Division, Sanofi, Frankfurt, Germany.
authors.forename: Hans
authors.initials: H
authors.lastname: Gassenhuber
authors.affiliation: German Diabetes Center, Paul-Langerhans-Group for Integrative Physiology, Düsseldorf, Germany eckel@uni-duesseldorf.de.
authors.forename: Jürgen
authors.initials: J
authors.lastname: Eckel
mesh_terms: D017667:Adipocytes / Q000166:cytology*; D000818:Animals; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism*; D005353:Fibronectins / Q000494:pharmacology*; D020935:MAP Kinase Signaling System / Q000502:physiology*; D008297:Male; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism*
chemical_list: D005353:Fibronectins; D048049:Extracellular Signal-Regulated MAP Kinases; D048051:p38 Mitogen-Activated Protein Kinases